Valsarpin 5 mg/160 mg
Valsarpin 5 mg/160 mg is a medicine authorised by Swissmedic under authorisation number 69431. The authorisation holder is Lagap SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 30 January 2025 and the authorisation is limited until 29 January 2030. ATC code C09DB01 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 69431 |
|---|---|
| Name | Valsarpin 5 mg/160 mg |
| Full name | Valsarpin 5 mg/160 mg, compresse rivestite con film |
| Authorisation holder | Lagap SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09DB01 |
| First authorisation | 30 January 2025 |
| Authorisation validity | 29 January 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Valsarpin 5 mg/160 mg, compresse rivestite con film | B | 30 January 2025 |
| 2 | Valsarpin 10 mg/160 mg, compresse rivestite con film | B | 30 January 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | C09DB01 | 02.07.2. | B |
| 2 | 28 | Tablette(n) | C09DB01 | 02.07.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Valsarpin 5 mg/160 mg authorised in Switzerland?
Yes. Valsarpin 5 mg/160 mg is authorised by Swissmedic under authorisation number 69431, data as of 01 September 2026. The authorisation is limited until 29 January 2030.
Which dispensing category does Valsarpin 5 mg/160 mg have?
Valsarpin 5 mg/160 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Valsarpin 5 mg/160 mg?
The authorisation holder is Lagap SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.